Novo Nordisk just pulled Wegovy from a major telehealth platform over safety concerns about knockoff versions. Here's what ...

Novo Nordisk (NVO) said it expanded patient access to Wegovy through a new collaboration with WeightWatchers, beginning July 1. WeightWatchers will work with CenterWell Pharmacy as the dispensing ...

MHRA launches genetic study into GLP-1 drug risks as Spain investigates Novo Nordisk for potential advertising violations.

Uninsured or self-pay obesity patients can get any dose of Wegovy for $299 from July 1–31, 2025. Patients can get their ...

A new bill could make the price of prescription drugs known for weight loss cheaper for the state of Ohio to buy for its ...

Up 4:32 pm The Vanguard S&P 500 ETF closed Thursday at 564.20, up 0.8%. Game On for Meta 1:33 pm Bloomberg is reporting that ...

Novo Nordisk (NVO) is broadening patient access to its FDA-approved weight management drug, Wegovy (semaglutide) 2.4 mg, ...

A US study by the Centers for Disease Control reveals the drug hospitalises nearly 70 people daily in America. CEO of Calocurb, a natural appetite suppressant company, Sarah Kennedy, says this is ...

Novo Nordisk continues to expand its partnerships with telehealth companies to broaden access to its blockbuster weight loss ...

Multiple pharmacists have told our newsroom it's set to hit New Zealand shelves next week. It's not funded by Pharmac, so users will have to pay and get a prescription for the weekly injectable which ...

A bill would allow Ohio state employees to purchase GLP-1s from manufacturers, then would require the Department of ...